Clinical trial Recruiting at 1 site Observational Ages 30 to 80

Observing sleep disorders in patients with neurodegenerative diseases

Official title: A Registered Observational Cohort Study on Neurodegenerative Associated With Sleep Disorder.

Run by Fujian Medical University Union Hospital · NCT05524922 · Data updated 2026-11-12

This study looks at how sleep problems affect people with neurodegenerative diseases to better understand their impact on thinking and memory.

Quick facts

Study typeObservational
Ages30 Years to 80 Years
SexAll
Enrollment500 (estimated)
SponsorFujian Medical University Union Hospital
Academic / other
Locations1 site (Fuzhou, Fujian)
StatusRecruiting
StartedSeptember 1, 2021
Main results expectedJune 1, 2030
Study endsJune 1, 2030
Registry record updatedJanuary 22, 2025
Trial IDNCT05524922 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a clinical diagnosis of a neurodegenerative disease who experience significant sleep disturbances.

Probably not a fit

Patients with other neurological disorders unrelated to neurodegenerative diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the relationship between sleep disorders and the progression of neurodegenerative diseases. It will collect data on clinical manifestations, imaging results, and biological markers associated with sleep disturbances in affected patients. The study focuses on individuals diagnosed with neurodegenerative disorders who experience various sleep-related issues, such as insomnia and excessive daytime sleepiness. By analyzing these factors, the study seeks to enhance understanding of how sleep disorders impact cognitive impairment in neurodegenerative conditions.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for sleep disorders in patients with neurodegenerative diseases, potentially enhancing their quality of life.

How similar studies have gone: While there is ongoing research into sleep disorders in neurodegenerative diseases, this specific observational approach may provide novel insights into their relationship.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. clinical diagnosis of neurodegenerative disease.
2. patients experience insomnia, excessive drowsiness, or confusion at night.
3. Patients experience frequent awakenings, daily sleep episodes, or nocturnal confusion.
4. The presence of one or more of the following characteristics: a. wandering at night with inappropriate activity; b. agitation, combativeness; c. confusion, disorientation, or marked delirium.
5. Polysomnographic monitoring showed the following two conditions: a. poor sleep efficiency, increased number and duration of awakenings; b. multiple sleep latency tests showed increased daytime sleepiness.
6. Presence of other medical symptoms that do not indicate the primary disease.
7. Other sleep disorders (e.g., periodic limb movement disorders, obstructive sleep apnea syndrome) may be present, but do not explain the patient 's main symptoms.
8. any of the above can be diagnosed

Exclusion Criteria:

1. Patients with other neurological disorders.
2. Pregnant or lactating women.

Where it's running

  • Fujian Medical University Union Hospital
    Fuzhou, Fujian, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.